Lucas Montarce
Executive Vice President And Chief Financial Officer
Eli Lilly and Company · LLY
$8.5M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 20, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1M
- Stock Awards
- $7.2M
- Other
- $303K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,000,000 | $7,180,000 | $8,483,315 |
| 2024 | $664,639 | $2,181,693 | $2,948,519 |
Current Position
- Company
- Eli Lilly and Company
- Title
- Executive Vice President And Chief Financial Officer
- Ticker
- LLY · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 20, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
Accession 0000059478-26-000029.
Other Eli Lilly Executives
David A. Ricks
Chair, President, And Chief Executive Officer
Eli Lilly · LLY
$36.7M
FY 2025 · DEF 14A
Daniel M. Skovronsky
M.D., Ph.d. Executive Vice President, Chief Scientific And Product Officer And President, Lilly Research Labs
Eli Lilly · LLY
$17.8M
FY 2025 · DEF 14A
Anat Hakim
Executive Vice President, General Counsel And Secretary
Eli Lilly · LLY
$9.8M
FY 2025 · DEF 14A
Jake Van Naarden
Executive Vice President And President, Lilly Oncology And Head Of Corporate Business Development
Eli Lilly · LLY
$7.6M
FY 2025 · DEF 14A